corticotropin-releasing hormone

(redirected from Corticotrophin-releasing factor)
Also found in: Medical, Encyclopedia.

cor·ti·co·tro·pin-re·leas·ing hormone

n. Abbr. CRH
A hormone produced by the hypothalamus that stimulates the anterior pituitary gland to release adrenocorticotropic hormone.
Mentioned in ?
References in periodicals archive ?
Exposure of the non-treated rats to NMS, RS or NMS/RS resulted in an increase in plasma level of the stress hormones corticotrophin-releasing factor and corticosterone, statistically significant in the RS and NMS/RS rats.
The separated plasma was subsequently stored at -20[degrees]C for determination of corticotrophin-releasing factor (CRF) levels using rat specific ELISA kit obtained from Hoelzel Diagnostics GmbH (Cologne, Germany) and corticosterone levels using rat specific ELISA kit obtained from Assaypro (St.
Humans respond to stress via the HPA axis, activation of corticotrophin-releasing factor outside the hypothalamus and activation of sympathetic nervous system via adrenaline or noradrenaline.
The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats.
Corticotrophin-releasing factor (CRF) acts through CRF-2 receptors of medulla to inhibit such stress related delay in GET (14).
In rats, oxytocin and corticotrophin-releasing factor neurons co-localized in the paraventricular nucleus and bed nucleus of the stria terminalis strongly suggest that they provide a crucial feedback loop between these 2 systems that could significantly impact affective and social behaviors, particularly during times of stress.
Chen is responsible for the design, synthesis and development of NBI-30775 (R121919), a small molecule antagonist of the corticotrophin-releasing factor receptor as the first-in-class compound advanced into clinical trials for depression/anxiety.
With age, mice produced a stress hormone called corticotrophin-releasing factor, or CRF that is associated with hair loss.
In addition, researchers are evaluating the therapeutic potential of corticotrophin-releasing factor antagonists and neurokinin 1 antagonists, which may address the relationship between stress and alcohol consumption.
Pathways involved in gut mucosal barrier dysfunction induced in adult rats by maternal deprivation: corticotrophin-releasing factor and nerve growth factor interplay.